Foghorn Therapeutics (FHTX) EBITDA Margin Growth (1y) (2021 - 2026)
Foghorn Therapeutics (FHTX) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Foghorn Therapeutics | 352.57 Mn | 263.66 Mn | - | -27,537.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27,537.00 |
| Dec 31, 2025 | 58,229.00 |
| Sep 30, 2025 | 7,856.00 |
| Jun 30, 2025 | 10,747.00 |
| Mar 31, 2025 | 17,333.00 |
| Dec 31, 2024 | -39,922.00 |
| Sep 30, 2024 | -20,775.00 |
| Jun 30, 2024 | 18,578.00 |
| Mar 31, 2024 | 6,926.00 |
| Dec 31, 2023 | 32,080.00 |
| Sep 30, 2023 | 32,824.00 |
| Jun 30, 2023 | 7,764.00 |
| Mar 31, 2023 | 8,173.00 |
| Dec 31, 2022 | 317,648.00 |
| Sep 30, 2022 | 6.36 Mn |
| Jun 30, 2022 | 768,721.00 |
| Mar 31, 2022 | 737,813.00 |
| Dec 31, 2021 | 433,992.00 |
| Sep 30, 2021 | -5.37 Mn |